Drug
Baxdrostat Dapagliflozin
Baxdrostat Dapagliflozin: highest development phase Phase 3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Baxdrostat/dapagliflozin NCT06742723 | Phase 3 | Chronic Kidney Disease and Hypertension |
Latest
No recent events.
Follow Baxdrostat Dapagliflozin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.